5340 |
PLASMINOGEN |
PLG |
173350 |
9071 |
ENSG00000122194 |
OTTHUMG00000015957 |
P00747 |
P02671 |
2243 |
ENSG00000171560 |
FIBA_HUMAN |
PLASMINOGEN PRECURSOR (EC 3.4.21.7) [CONTAINS: ANGIOSTATIN]. [SOURCE:UNIPROT/SWISSPROT;ACC:P00747] |
PLMN_HUMAN |
Plasmin light chain B |
Plasmin heavy chain A, short form |
Angiostatin |
Activation peptide |
Plasmin heavy chain A |
P07355 |
302 |
ANXA2_HUMAN |
ENSG00000182718 |
T89034 |
- |
HAE4 |
Target Class | Miscellaneous |
Target Subclass | StructuralAndAdhesion |
Target Subclass | Fibrinogen |
Target Class | Enzymes |
Target Subclass | EC:3.4.21.7 |
Target Main Class | Other |
Human Readable Name | DRUGGABLE GENOME |
Human Readable Name | PROTEASE |
Target Subclass | 3.4.21.7 |
Target Main Class | Enzymes |
Target Subclass | Enzyme Inhibitor |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Short Name | Peptidase_S1_S6 |
Interpro Type | Domain |
Interpro Acc | IPR001254 |
Interpro Name | Peptidase S1/S6, chymotrypsin/Hap |
Uniprot Status | Swiss-Prot |
Gene Biotype | PROTEIN_CODING |
CELL SURFACE |
PROTEASE |
DRUGGABLE GENOME |
activator (activating) |
Mechanism of Interaction | Plasminogen activator |
Direct Interaction | yes |
Trial Name | - |
activator (activating) |
Mechanism of Interaction | Plasminogen activator |
Direct Interaction | yes |
Trial Name | - |
activator (activating) |
Trial Name | reteplase,Retavase, Rapilysin |
Novel drug target | Established target |
Mechanism of Interaction | Plasminogen activator |
activator (activating) |
Trial Name | desmoteplase |
Novel drug target | Established target |
Mechanism of Interaction | Plasminogen activator |
activator (activating) |
Mechanism of Interaction | Plasminogen activator |
Direct Interaction | yes |
Trial Name | urokinase for injection,Kinlytic |
activator (activating) |
Mechanism of Interaction | Plasminogen activator |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Plasminogen inhibitor |
Direct Interaction | yes |
inhibitor (inhibitory) |
Mechanism of Interaction | Plasminogen inhibitor |
Direct Interaction | yes |
activator (activating) |
Novel drug target | Established target |
Trial Name | alteplase,Activase, Actilyse |
Mechanism of Interaction | Plasminogen activator |
inhibitor (inhibitory) |
Mechanism of Interaction | Plasminogen inhibitor |
Direct Interaction | yes |
n/a |
Trial Name | amediplase, K2tu-PA |
Novel drug target | Established target |
n/a |
Trial Name | Plasmin |
Novel drug target | Established target |
PLG | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
PLG | Gene Symbol |
Target Class | Miscellaneous |
Target Subclass | StructuralAndAdhesion |
Target Subclass | Fibrinogen |
ENSG00000182718 | Ensembl Gene Id |
ANXA2_HUMAN | Uniprot Id |
302 | Entrez Gene Id |
Target Subclass | Enzyme Inhibitor |
Target Main Class | Other |
PLMN_HUMAN | Uniprot Id |
PLG | Gene Symbol |
5340 | Entrez Gene Id |
Target Subclass | 3.4.21.7 |
Target Main Class | Enzymes |
P02671 | Uniprot Accession |
2243 | Entrez Gene Id |
PLG | Gene Symbol |
Target Subclass | Fibrinogen |
Target Main Class | Other |
Target Subclass | StructuralAndAdhesion |
PLASMINOGEN PRECURSOR (EC 3.4.21.7) [CONTAINS: ANGIOSTATIN]. [SOURCE:UNIPROT/SWISSPROT;ACC:P00747] | Description |
ENSG00000122194 | Ensembl Gene Id |
PLG | Display Id |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
P00747 | Uniprot Accession |
ENSG00000122194 | Ensembl Gene Id |
5340 | Entrez Gene Id |
Human Readable Name | PROTEASE |
Human Readable Name | DRUGGABLE GENOME |
Uniprot Evidence | 1: Evidence at protein level |
PROTEASE, DRUGGABLE GENOME |
ENSG00000122194 | Gene Symbol |
PLG | Ensembl Id |
DRUGGABLE GENOME |
PLG | GENE_SYMBOL |
Plasminogen | UNIPROT |
Plasmin heavy chain A | UNIPROT |
5340 | Gene ID |
- | dGene Synonym |
PROTEASE |
PLG | TTD Gene Abbreviation |
T89034 | TTD Target ID |
CELL SURFACE |